The National Cancer Institute (NCI) Small Business
Innovation Research (SBIR) Program has announced the FY2012 SBIR
Phase II Bridge Award, designed to support the next stage of development
for previously funded NIH-wide SBIR Phase II projects in the areas of cancer
therapeutics, imaging technologies, interventional devices, diagnostics and
prognostics. The NCI intends to commit up to $10 million in fiscal year 2012 to
fund up to ten new awards.
The Phase II Bridge Award helps to:
- "Bridge" the funding gap, known as the
"Valley of Death," that currently exists between the end of the SBIR
Phase II award and the next round of financing needed to advance a promising
cancer therapy or imaging technology toward commercialization.
- Incentivize partnerships between NIH's SBIR Phase II
awardees and third-party investors and/or strategic partners.
For information on how to apply, please review the Funding
Opportunity Announcement (FOA) at: http://grants1.nih.gov/grants/guide/rfa-files/RFA-CA-12-001.html
Available Funding:
Budgets up to $1 million in total costs per year and project periods up to
three years (a total of $3 million) may be requested from the NCI. Development
efforts may include pre-clinical R&D needed for regulatory filings (e.g. IND or PMA) or clinical
trials.
This FOA will give competitive preference and funding
priority to applications deemed likely to result in a commercial product as
indicated by the applicant's ability to secure substantial independent
third-party investor funds (i.e. third-party funds that equal or exceed the
requested NCI funds). Examples of third-party investors include drug or device
manufacturers, angel investors, venture capital investors, state investment
funds, foundations, and universities. Applicants must provide a
commercialization plan, which is expected to include details on any independent
third-party investor funding that has already been secured or will be provided
during the Bridge Award project period.
Eligibility:
-
The SBIR Phase II Bridge Award funding opportunity is open to current and
recently expired NIH SBIR Phase II projects.
- The application must represent a continuation of the R&D
efforts performed under a previously funded NIH SBIR Phase II award.
- Applications may be predicated on a previously funded SBIR
Phase II grant or contract award.*
- To be eligible under the current FOA, Phase II projects MUST
end on or before August 31, 2012.
- In general, past Phase II projects should have ended within
24 months of the application receipt date, although the NCI will consider
longer periods of hiatus on a case-by-case basis.
*NOTE: Applicants who intend to submit a Phase II Bridge
Award application that is predicated on an SBIR Phase II contract MUST contact
the SBIR Development Center
prior to submission, so that the NCI can properly arrange for such applications
to be accepted.
There are two deadlines to submit an SBIR Phase II Bridge
Award application in FY2012: December 28, 2011 & March 27, 2012.
We encourage you to learn
more about this opportunity and apply!
Learn about SBIR Phase II Bridge Awardees
Read about current
NCI SBIR Bridge Awardees and the cancer technologies they are developing to
improve detection and treatment for clinical use.
How to Apply
View
online resources and tips for applying that help small businesses prepare
their grant applications and contract proposals.
Resources for Small Business Applicants
The SBIR Development Center helps to build relationships with the business
community and researchers by supporting small business applicants, and by
fostering partnerships and collaborations between small businesses and
third-party organizations. If you are interested in discussing your
organization's project with NCI Development Center
staff to explore how it aligns with NCI's priorities, please contact a Program
Director at ncisbir@mail.nih.gov.